XML 18 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
INTERIM STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Common Stock
Upright Technologies Ltd
Common Stock
Physimax Technologies Ltd.
Common Stock
Preferred Stock [Member]
Additional Paid-in Capital [Member]
Upright Technologies Ltd
Additional Paid-in Capital [Member]
Physimax Technologies Ltd.
Additional Paid-in Capital [Member]
Accumulated deficit [Member]
Upright Technologies Ltd
Physimax Technologies Ltd.
Total
Balance at Dec. 31, 2020             $ 171,399,000 $ (143,248,000)     $ 28,151,000
Balance (in shares) at Dec. 31, 2020     8,119,493 15,823              
Payment for executives and directors under Stock for Salary Program             72,000       72,000
Payment for executives and directors under Stock for Salary Program (in shares)     5,579                
Exercise of options             201,000       201,000
Exercise of options (In Shares)     33,773                
Exercise of placement agent warrants (in shares)     92,575                
Exercise of Warrants             633,000       633,000
Exercise of Warrants (in shares)     219,760                
Issuance of common stock to consultants and service provider             1,484,000       1,484,000
Issuance of common stock to consultants and service provider (in shares)     102,667                
Conversion of preferred stock to common stock (in shares)     802,061 (3,423)              
Deemed dividend related to issuance of preferred stock             544,000 (544,000)      
Issuance of warrants to service providers             846,000       846,000
Stock-based compensation             2,036,000       2,036,000
Stock-based compensation (in shares)     1,056,643                
Issuance of common stock, net of issuance cost             64,877,000       64,877,000
Issuance of common stock, net of issuance cost (in shares)     3,278,688                
Issuance of common stock upon acquisition         $ 28,933,000       $ 28,933,000    
Issuance of common stock upon acquisition (in shares) 1,687,612                    
Net loss               (14,966,000)     (14,966,000)
Balance at Mar. 31, 2021             271,025,000 (158,758,000)     112,267,000
Balance (in shares) at Mar. 31, 2021     15,398,851 12,400              
Balance at Dec. 31, 2020             171,399,000 (143,248,000)     28,151,000
Balance (in shares) at Dec. 31, 2020     8,119,493 15,823              
Net loss                     (32,731,000)
Balance at Jun. 30, 2021             295,124,000 (177,011,000)     118,113,000
Balance (in shares) at Jun. 30, 2021     16,330,842 12,122              
Balance at Mar. 31, 2021             271,025,000 (158,758,000)     112,267,000
Balance (in shares) at Mar. 31, 2021     15,398,851 12,400              
Payment for executives and directors under Stock for Salary Program             27,000       27,000
Payment for executives and directors under Stock for Salary Program (in shares)     1,754                
Exercise of options             55,000       55,000
Exercise of options (In Shares)     6,772                
Exercise of placement agent warrants (in shares)     18,486                
Exercise of Warrants (in shares)     232                
Issuance of common stock to consultants and service provider             889,000       889,000
Issuance of common stock to consultants and service provider (in shares)     72,754                
Conversion of preferred stock to common stock (in shares)     64,369 (278)              
Deemed dividend related to issuance of preferred stock             488,000 (488,000)      
Issuance of warrants to service providers             1,951,000       1,951,000
Stock-based compensation             2,595,000       2,595,000
Stock-based compensation (in shares)     (500)                
Issuance of common stock upon acquisition             18,094,000       18,094,000
Issuance of common stock upon acquisition (in shares)     768,124                
Net loss               (17,765,000)     (17,765,000)
Balance at Jun. 30, 2021             295,124,000 (177,011,000)     118,113,000
Balance (in shares) at Jun. 30, 2021     16,330,842 12,122              
Balance at Dec. 31, 2021     $ 2,000       307,561,000 (222,014,000)     85,549,000
Balance (in shares) at Dec. 31, 2021     16,573,420 11,927              
Exercise of Warrants (in shares)     81,221                
Issuance of common stock to directors and employees             161,000       161,000
Issuance of common stock to directors and employees (in shares)     24,191                
Issuance of common stock to consultants and service provider             113,000       113,000
Issuance of common stock to consultants and service provider (in shares)     4,983                
Conversion of preferred stock to common stock (in shares)     316,052 (1,030)              
Deemed dividend related to issuance of preferred stock             451,000 (451,000)      
Issuance of warrants to service providers             1,301,000       1,301,000
Stock-based compensation             3,768,000       3,768,000
Stock-based compensation (in shares)     139,982                
Issuance of common stock, net of issuance cost (in shares)                   256,660  
Issuance of common stock upon acquisition           $ 1,186,000       $ 1,186,000  
Issuance of common stock upon acquisition (in shares)   256,660                  
Issuance of common stock and pre-funded warrants, net of issuance cost             38,023,000       38,023,000
Issuance of common stock and pre-funded warrants, net of issuance cost (in shares)     4,674,454                
Net loss               (15,916,000)     (15,916,000)
Balance at Mar. 31, 2022     $ 2,000       352,564,000 (238,381,000)     114,185,000
Balance (in shares) at Mar. 31, 2022     22,070,963 10,897              
Balance at Dec. 31, 2021     $ 2,000       307,561,000 (222,014,000)     85,549,000
Balance (in shares) at Dec. 31, 2021     16,573,420 11,927              
Net loss                     (33,944,000)
Balance at Jun. 30, 2022     $ 2,000       356,492,000 (256,842,000)     99,652,000
Balance (in shares) at Jun. 30, 2022     22,860,044 10,797              
Balance at Mar. 31, 2022     $ 2,000       352,564,000 (238,381,000)     114,185,000
Balance (in shares) at Mar. 31, 2022     22,070,963 10,897              
Issuance of common stock to consultants and service provider             74,000       74,000
Issuance of common stock to consultants and service provider (in shares)     7,977                
Conversion of preferred stock to common stock       $ (100)              
Conversion of preferred stock to common stock (in shares)     23,365                
Deemed dividend related to issuance of preferred stock             433,000 (433,000)      
Issuance of warrants to service providers             557,000       557,000
Stock-based compensation             2,998,000       2,998,000
Stock-based compensation (in shares)     816,396                
Net loss               (18,028,000)     (18,028,000)
Repurchase and retirement of common stock             (134,000)       (134,000)
Repurchase and retirement of common stock (in shares)     58,657                
Balance at Jun. 30, 2022     $ 2,000       $ 356,492,000 $ (256,842,000)     $ 99,652,000
Balance (in shares) at Jun. 30, 2022     22,860,044 10,797